Novartis AG Sponsored ADR revenue breakdown overview

Novartis AG Sponsored ADR revenue for the last year amounted to 50.32 B USD, the most of which — 14.74 B USD — came from its highest performing source at the moment, Oncology, the year earlier bringing 13.59 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Novartis AG Sponsored ADR 21.15 B USD, and the year before that — 17.96 B USD.